Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia A Cane

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Journal of Medical Virology|October 12, 2002
Analysis of HIV-1 variation in blood and semen during treatment and treatment interruptionBhudipa Choudhury, Deenan Pillay, Stephen Taylor, et al.
AIDS (London, England)|April 13, 2004
HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapyStéphane Hué, Jonathan P Clewley, Patricia A Cane, et al.
Antiviral Therapy|February 12, 2011
HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysisAndrew J Buckton, Ross J Harris, Deenan Pillay, et al.
Influenza and Other Respiratory Viruses|October 11, 2008
Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military trainingMatthew K O'Shea, Christopher Pipkin, Patricia A Cane, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication FitnessSupang A Martin, Patricia A Cane, Deenan Pillay, et al.
The Journal of General Virology|November 1, 2013
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1Katherine A Sutherland, Jean L Mbisa, Patricia A Cane, et al.
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
AIDS Research and Human Retroviruses|March 19, 2013
Dynamics of HIV type 1 recombination following superinfectionFransje A Koning, Anjna Badhan, Simon Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2015
Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United KingdomJean L Mbisa, Esther Fearnhill, David T Dunn, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Journal of Medical Virology|October 12, 2002
Analysis of HIV-1 variation in blood and semen during treatment and treatment interruptionBhudipa Choudhury, Deenan Pillay, Stephen Taylor, et al.
AIDS (London, England)|April 13, 2004
HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapyStéphane Hué, Jonathan P Clewley, Patricia A Cane, et al.
Antiviral Therapy|February 12, 2011
HIV type-1 drug resistance in treatment-naive patients monitored using minority species assays: a systematic review and meta-analysisAndrew J Buckton, Ross J Harris, Deenan Pillay, et al.
Influenza and Other Respiratory Viruses|October 11, 2008
Respiratory syncytial virus: an important cause of acute respiratory illness among young adults undergoing military trainingMatthew K O'Shea, Christopher Pipkin, Patricia A Cane, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication FitnessSupang A Martin, Patricia A Cane, Deenan Pillay, et al.
The Journal of General Virology|November 1, 2013
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1Katherine A Sutherland, Jean L Mbisa, Patricia A Cane, et al.
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
Three residues in HIV-1 matrix contribute to protease inhibitor susceptibility and replication capacityChris M Parry, Madhavi Kolli, Richard E Myers, et al.
AIDS Research and Human Retroviruses|March 19, 2013
Dynamics of HIV type 1 recombination following superinfectionFransje A Koning, Anjna Badhan, Simon Shaw, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2015
Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United KingdomJean L Mbisa, Esther Fearnhill, David T Dunn, et al.
Pageof 8